Takotsubo Syndrome and Embolic Events
Ibrahim El-Battrawy1, Martin Borggrefe1, Ibrahim Akin1
1First Department of Medicine, Medical Faculty Mannheim, University Heidelberg, Theodor-Kutzer-Ufer 1-3, Mannheim 68167, Germany; DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Theodor-Kutzer-Ufer 1-3, Mannheim 68167, Germany.
Insights
Takotsubo cardiomyopathy (TTC) can lead to thromboembolism, including stroke and ventricular thrombi. Patients with high C-reactive protein, D-dimers, and impaired left ventricular function face higher risks, suggesting a need for careful monitoring and potential anticoagulation.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Takotsubo cardiomyopathy (TTC), once considered benign, presents significant complications.
- Thromboembolism, manifesting as stroke or peripheral embolization, is a critical complication of TTC.
Purpose of the Study:
- To highlight the risk factors and potential management strategies for thromboembolic complications in Takotsubo cardiomyopathy.
- To draw parallels between TTC and acute myocardial infarction management for thromboembolic events.
Main Methods:
- Review of clinical presentations and risk factors associated with thromboembolism in TTC patients.
- Analysis of biomarkers (C-reactive protein, D-dimers) and left ventricular function in predicting risk.
- Comparison with established treatment protocols for thromboembolism in acute myocardial infarction.
Main Results:
- Elevated C-reactive protein, markedly elevated D-dimers, and severely impaired left ventricular function are identified as high-risk indicators for thromboemboli in TTC.
- Thromboembolic events can occur at the onset or during the course of TTC.
Conclusions:
- Thromboembolism is a serious complication of Takotsubo cardiomyopathy requiring vigilant management.
- Anticoagulation, similar to acute myocardial infarction protocols, may be considered for TTC patients with thromboembolic complications.
- Individualized, close follow-up is crucial to prevent relapse and manage dynamic myocardial stunning complications.
Abstract:
Takotsubo cardiomyopathy (TTC), initially defined as a benign disease, is associated with several complications. One of them is a thromboembolism, which is clinically presented by events such as stroke, ventricular thrombi, and peripheral embolization, and can be present at index event of TCC as well as at any time in disease course. Patients with elevated C-reactive protein levels, markedly elevated D-dimers and severely impaired left ventricular function seem to be at higher risk of developing thrombemboli. Treatment strategies prescribed in the management of thombembolic complications in patients with acute myocardial infarction includes a short course of anticoagulation. A similar analogy could also be considered for patients with TTC presenting with this complications. Nevertheless, an individualized close-follow-up is of utmost importance to avoid any relapse and not to oversee any impeding complications in light of dynamic processes in myocardial stunning.
Related Concept Videos
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome I: Introduction
01:29Pulmonary Embolism I: Introduction
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:30Acute Coronary Syndrome III: Diagnostic Studies